Daré Bioscience Partners with MyMenopauseRx to Expand Menopause Care Access

Corporate Action
โดย GlobeNewswire·Read original
Summary · why it matters

Daré Bioscience has launched a strategic collaboration with MyMenopauseRx, a specialized telehealth platform focused exclusively on menopause care. Under the collaboration, MyMenopauseRx will be featured as a menopause-specific telehealth partner for DARE to PLAY Sildenafil Cream, giving women seeking dedicated menopause care alongside arousal support access to a menopause specialist through MyMenopauseRx, with options for lifestyle counseling, bioidentical hormonal treatment and more, available by insurance or cash pay. This option sits alongside DARE to PLAY's existing telehealth questionnaire and the option to consult a woman's own provider. The collaboration is part of Daré's strategy to build a broader women's health ecosystem that connects its innovative products with education, clinical expertise and access to care. MyMenopauseRx currently serves women in 42 states, and most of its services are covered by commercial insurance.

Impact on stocks 1

Health Care · 1 stocks
Dare Bioscience Inc
DARE
▲ PositiveDemandrelevance

Partnership with MyMenopauseRx expands access to DARE to PLAY Sildenafil Cream, potentially increasing product adoption.

Off-coverage companies 1

MyMenopauseRxPrivate▲ Positive
Demandrelevance

Collaboration with Daré Bioscience adds a new product offering to MyMenopauseRx's platform, potentially attracting more patients.